Kestra Investment Management LLC Takes $690,000 Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Kestra Investment Management LLC purchased a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 16,951 shares of the real estate investment trust's stock, valued at approximately $690,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Assetmark Inc. increased its position in shares of Omega Healthcare Investors by 1.7% during the 3rd quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock valued at $48,492,000 after purchasing an additional 19,542 shares during the last quarter. Daiwa Securities Group Inc. increased its position in shares of Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock valued at $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. Caxton Associates LP purchased a new stake in shares of Omega Healthcare Investors during the 2nd quarter valued at about $1,652,000. Van ECK Associates Corp increased its position in shares of Omega Healthcare Investors by 15.4% during the 3rd quarter. Van ECK Associates Corp now owns 100,145 shares of the real estate investment trust's stock valued at $4,167,000 after purchasing an additional 13,367 shares during the last quarter. Finally, Cetera Advisors LLC purchased a new stake in Omega Healthcare Investors in the 1st quarter worth approximately $646,000. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Trading Down 1.5 %

OHI traded down $0.59 during trading on Monday, reaching $40.02. The company had a trading volume of 477,120 shares, compared to its average volume of 1,681,265. The stock has a market cap of $10.80 billion, a P/E ratio of 29.68, a PEG ratio of 1.26 and a beta of 0.99. The business has a 50 day simple moving average of $40.61 and a 200-day simple moving average of $37.40. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.70%. Omega Healthcare Investors's payout ratio is 197.06%.

Insiders Place Their Bets

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on OHI. Truist Financial increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. BNP Paribas raised shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective for the company in a report on Thursday, October 31st. BMO Capital Markets increased their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a "market perform" rating in a research report on Monday, October 7th. Berenberg Bank assumed coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a "buy" rating and a $45.00 target price for the company. Finally, Scotiabank increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research report on Monday, August 26th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $40.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.